SCHEMBL1492963

SCHEMBL1492963

Cc1cc(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3Cl)cc2)ccn1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 7/20 0.74
PSEN2 P49810 7/20 0.74
APH1B Q8WW43 7/20 0.74
NCSTN Q92542 7/20 0.74
APH1A Q96BI3 7/20 0.74
PSENEN Q9NZ42 7/20 0.74
RIPK1 Q13546 2/20 0.61
CYP2D6 P10635 4/20 0.59
KDR P35968 4/20 0.56
BRAF P15056 2/20 0.56
FLT1 P17948 1/20 0.54
TEK Q02763 1/20 0.54
RAF1 P04049 1/20 0.51
RORA P35398 1/20 0.51
NR2E1 Q9Y466 1/20 0.51
CHRNA7 P36544 1/20 0.50
NTRK1 P04629 1/20 0.50
MEN1 O00255 1/20 0.49
LMNA P02545 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1493059 0.89 PSEN1 (0.73) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492951 0.88 PSEN1 (0.72) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492765 0.85 MEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492877 0.85 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492973 0.85 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1493010 0.82 PSEN1 (0.80) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492835 0.82 PSEN1 (0.57) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL15435517 0.81 CYP1A2 (0.62) RIPK1CYP2D6KDRFLT1TEK
SCHEMBL2184754 0.81 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL27830099 0.81 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083794-A Urea compounds as gamma secretase modulators AMGEN INC 2011-06-01 CN claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 PSEN1 3/4885PSEN2 4/4885APH1B 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.